SUBSCRIBE: Print / eNewsletter
Adding Indoximod to Pembrolizumab Improved Response Rate in Advanced Melanoma
This video examines phase II results of a single-arm trial that tested checkpoint inhibition plus the IDO–pathway inhibitor indoximod in patients with melanoma.
Copanlisib Yields Responses in Relapsed/Refractory Non-Hodgkin Lymphoma
This video reviews results of the phase II CHRONOS-1 trial, a single-arm study evaluating the investigational agent copanlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma.
CTCs and Circulating Tumor DNA for the Monitoring of Breast Cancer Patients
In this interview we discuss the use of CTCs and circulating tumor DNA for prognosis and disease monitoring in patients with breast cancer.
FGFR Inhibitor Shows Preclinical Activity in Breast Cancer
This video highlights preclinical activity of a novel FGFR inhibitor that has been tested alone and in combination with antihormonal therapy in breast cancer cell lines.
Immunotherapy Combination Promising in Advanced Melanoma
The combination of an intratumoral injection of CVA21 and ipilimumab has demonstrated durable response with minimal toxicity in patients with advanced melanoma.